JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Psychedelics as prophylactic neuroprotectants.

Science (New York, N.Y.) September 3, 2026 DOI: 10.1126/science.aek3865 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed
Key points	The abstract claims that a compound from certain mushrooms prevents nerve damage during chemotherapy, but provides no details on the compound, study design, or evidence.

Abstract

A compound found in certain mushrooms prevents nerve damage during chemotherapy.

Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation. Science (New York, N.Y.) September 3, 2026
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders Journal of Neurochemistry September 14, 2021 78 citations
Psychedelics as therapeutics Suchttherapie August 1, 2026
Psychedelics and neuroregenerative medicine: Illuminating the potential of psychoplastogens for neurodevelopment and central nervous system repair Psychedelics September 8, 2026
Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 2025